Remdesivir is an experimental antiviral drug made by the company Gilead. Designed to act against the RNA driven RNA polymerase enzyme in RNA viruses, it was initially tested on Ebola.
Since coronaviruses are also RNA viruses, Remdesivir is expected to work on them, too.
